Publicaciones científicas

Molecular characterization of small peripheral lung tumors based on the analysis of fine needle aspirates

I. Zudaire (1,2), M.D. Lozano (3), M.F. Vazquez (4), M.J. Pajares (1,5), J. Agorreta (1,5), R. Pio (1,6), J.J. Zulueta (7), D.F. Yankelevitz (8), C.I. Henschke (9) and L.M. Montuenga (1,5)
(1)Oncology Division, Center for Applied Medical Research, (3)Departments of Pathology, and (7)Neumology, Clínica Universitaria de Navarra and (2)Departments of Genetics, (6)Biochemistry and (5)Histology and Pathology, Schools of Medicine and Sciences, University of Navarra, Pamplona, Spain, Departments of (4)Pathology and (8)Radiology, Weill Medical College of Cornell University, New York, USA

Revista: Histology and Histopathology

Fecha: 01-ene-2008

Neumología Anatomía Patológica

The computed tomography (CT)-based early lung cancer diagnostic technologies allow the detection of very small stage I lung tumors. As part of these screening protocols any suspicious nodule has to be diagnosed morphologically, which requires CT-guided Fine Needle Aspiration, open biopsy or surgery. Fine Needle Aspiration (FNA) cytology is a well-recognised method for a rapid and accurate diagnosis of small lung tumors.

Molecular analysis of the FNA specimens could complement cytology diagnosis by the characterization of the biological traits at the preoperative stage. In this study, we aimed to characterize the biological profile of 33 paraffin-embedded transthoracic FNA samples obtained from three groups of lung cancer patients: two groups of small early-detected lung adenocarcinomas (radiologically subsolid and solid nodules) and a third group of small metastatic adenocarcinomas. Genetic analysis was performed by fluorescence in situ hybridization using the four-color LAVysion probe. p53 and Ki-67 protein expression was also evaluated by immunocytochemistry. The samples showed gains for all targets analyzed; two cases had EGFR gene amplification and two cases had MYC amplification. There were no significant differences in the percentage of genetically malignant cells and the expression of Ki-67 among the three groups. However, p53 accumulation was significantly higher in the metastatic group compared to the subsolid early-detected group (P = 0.001).

In conclusion, molecular analysis of FNA specimens may provide useful information at preoperative stages. In our series, a good prognostic profile in subsolid early detected adenocarcinomas is suggested.

CITA DEL ARTÍCULO  Histol Histopathol. 2008 Jan;23(1):33-40



La Clínica es el hospital privado con mayor dotación tecnológica de España, todo en un único centro.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra


Los profesionales de la Clínica realizan una labor continuada de investigación y formación, siempre en beneficio del paciente.

Imagen profesionales de la Clínica Universidad de Navarra


Conozca por qué somos diferentes a otros centros sanitarios. Calidad, rapidez, comodidad y resultados.

Imagen del edificio de la Clínica Universidad de Navarra